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Lipinski’s rules applied to drug bioavailability
the 90s were gloomy years for the pharmaceutical indus-
try with productivity falling below expectations. Indeed, 
the ten leading companies’ newly marketed compounds 
increased their revenues by only ~10 %, and the average 
innovation deficit was ~1.3–1.8 new chemical entities 
per year (Drews 2003). As the time from drug discovery 
to launch is currently ~12 years and costs ~$750 million/
drug, the pharmaceutical industry is determined to reduce 
both the cost and time scale of this process; it is, therefore, 
understandable that the strategies adopted by these com-
panies are those which provide information in advance of 
costly clinical trials. A significant obstacle to this is deter-
mining the properties of a drug that facilitate its delivery 
to, and uptake by, target tissues and/or cells to avoid unsuc-
cessful but nonetheless expensive clinical trials.
the bioavailability of drugs and hence their ability 
to interact with their targets can be summarized by four 
notions grouped under the acronym ADME, which stands 
for absorption, distribution, metabolism, and excretion. 
Each of these notions involves a particular aspect of the 
physiological interactions between body tissues and drugs, 
which explain drug bioavailability.
to circumvent the inherent difficulty linked to ADME-
related problems, Lipinski and collaborators produced a set 
of rules to identify the optimum physicochemical proper-
ties required for an oral compound to achieve maximum 
bioavailability, i.e. to cross all biological barriers before 
reaching its target. they studied all marketed drugs and 
deduced similarities or common important properties of all 
the different active compounds. In this context they formu-
lated a set four rules known, today, as Lipinski’s rules.
the first rule is based on the lipophilic index of drugs 
(octanol–water partitioning: log P < 5). the second rule is 
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based on the drugs’ molecular weight (MW), which must 
be <500. the third and fourth rules are based on the nature 
of the charge on the drugs (number of hydrogen-bond 
donors, i.e. number of Oh + Nh bonds <5; and num-
ber of hydrogen bond acceptors, i.e. number of O + N 
atoms <10). together, these rules define the 90th percen-
tile of the physicochemical properties drugs should have to 
achieve the greatest bioavailability (Lipinski et al. 2001). 
Because these rules were formulated for synthetic chemi-
cals, they were initially criticized, because many drugs are 
natural compounds; it was later found, however, that natu-
ral compounds, unsurprisingly, also follow Lipinski’s rules 
(Quinn et al. 2008). these rules are now established mod-
els for drug discovery and have been largely embraced by 
the pharmaceutical industry. however, a full and systematic 
scientific investigation of the way drugs interact with cells 
or tissues to generate these rules is still in its infancy and 
has yet to be fully conducted.
What is remarkable however is that although these rules 
may involve macro complex systems (the body), they seem 
to be equally important when single cells are considered.
Lipinski’s rules applied to drug entry into cells
Of the four rules, the second (MW <500) stands out 
because of its apparent simplicity, being unrelated to the 
complex physicochemical properties of a drug (as are 
its charge state or lipophilicity) but governed solely by a 
drug’s size or volume. In addition, although bioavailability 
is often considered in terms of biochemical interaction, the 
MW does not involve such interactions because it is not 
implicated in defining affinity between chemicals.
When physicists or biophysicists consider the MW of 
chemicals they consider the size or volume of the chemical. 
In physics, volume is important because it helps to define 
pressure, i.e. force per unit surface area. said differently, 
if the MW of a chemical is involved in Lipinski’s second 
rule it is because pressure must be present so MW is an 
important property. to be bioavailable, drugs must traverse 
cellular barriers (usually epithelia), and to traverse cellular 
barriers drugs must cross lipid membranes. It is natural to 
believe the MW of chemicals is important because of the 
surface pressure that exists in bilayer membranes. Natu-
rally, this conclusion is true only if chemicals are not dif-
fusing across the membrane via specific membrane pores 
(e.g. aquaporins).
the membrane surface pressure results from optimiza-
tion of the energies involved in lipid–lipid interactions 
(rauch 2009b). Many different lipids form the membrane 
and the cell uses much energy conserving the important 
heterogeneity involved in membrane integrity. two main 
types of energy are involved in systems composed of 
lipids, one linked to the attraction between lipids and the 
other linked to the repulsion between them. the source of 
attraction between lipids is related to their aliphatic chains, 
which have no affinity for water and, as a result, lipids will 
do their best to avoid increasing their free surface area in 
the membrane, to minimize contact with water. the source 
of repulsion, however, is linked to electrostatic or steric 
repulsion involving polar momentum, electrostatic charges 
of the lipid hard core that will try to increase the free sur-
face area per lipid. In soft systems, for example cell mem-
branes, there is no frustration linked to uncompensated 
energy. this means that the system tries to be in a mini-
mum energy state. the minimum energy state for a bilayer 
membrane is defined by the optimum cross-sectional area 
per membrane lipid, taking into consideration the afore-
mentioned repulsion and attraction (Annexes 1 and 2).
Incorporation of any drug into a lipid bilayer membrane 
will, therefore, perturb the minimum energy state of the 
membrane by forcing lipids into closer contact––i.e. by forc-
ing the packing of the lipids. As a response, the membrane 
will try to expel the drug from the lipid phase to re-establish 
the equilibrium. It is now clear that the larger the drug the 
greater the perturbation of the membrane. As a result lipids 
will apply a force against entry of drugs into the membrane 
that is necessarily a function of their size. In this context, 
a sort of Lipinski’s second rule concerning the molecular 
weight of drugs can be applied at the cellular level.
One thing which must be clarified, however, is that a 
membrane is not randomly composed. some lipids are 
more abundant on one leaflet than on the other, which cre-
ates dissymmetry (seigneuret and Devaux 1984). Further-
more, packing of lipids on each leaflet (i.e. the surface pres-
sure of each leaflet) is not the same on the outer and inner 
leaflets. the surface pressure of the inner leaflet is slightly 
more important than that of the outer leaflet, which is 
involved in endocytosis (Fig. 1) (rauch and Farge 2000a).
 together, the outer and inner leaflets create a perfect 
barrier to drugs. In this context it is possible to define what 
would be the theoretical MW limit (details are given in 
Annex 1):
where, kB is Boltzmann’s constant, T the temperature in 
Kelvin, R the vesicular radius, h the membrane thickness, 
and kc the membrane bending modulus. this equation pro-
vides a law with regard to drug size (or MW) selectivity for 
permeation across cellular membranes. Use of the numeri-
cal values of physical constants and biological properties 
reveals that MWc ∼= 250–500  at 37 °c (rauch and pluen 
2007). the larger value of this range is remarkably close to 
Lipinski’s second rule. A representation of Eq. 1 is given in 
Fig. 2.
In this context of mechanical filtration of drugs on the 
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entry of drugs. An interesting case is cancer, in which the 
ph gradient across the membrane can drive or control the 
influx of drugs.
Lipinski’s rules applied to drug entry into cancer cells, 
for which ph is an important condition
cancer cells are exquisitely difficult to control and, ulti-
mately, to kill. there are many reasons for this; one of 
direct interest is the notion that entry of drugs into cells 
(i.e. Lipinski’s rule for cells) seems to be linked to the ph 
gradient across the cell membrane.
A crucial event (cause or effect) in the transformation 
of normal cells into cancerous cells was discovered in 
1924 by Otto Warburg, who first described a switch of 
metabolism (i.e. cellular respiration) to glycolysis (ten-
nant et al. 2009) despite the relative inefficiency of this 
ExocytosisEndocytosis
Fig. 1  the lipid number asymmetry-induced fluid phase endocyto-
sis model. schematic diagram of the current model applied to living 
cells which links fluid phase endocytosis and membrane phospho-
lipid number asymmetry maintained by a flippase. In the left figure, 
the translocation of dark-head lipids into the inner leaflet induces 
differential lipid packing between leaflets (different surface tension) 
leading to membrane bending and vesiculation (Farge et al. 1999; 
rauch and Farge 2000b). Note that it is assumed that the membrane 
recycling that occurs in cells, i.e. the exocytosis of vesicles of a size 
similar to endocytic vesicles, also enables maintenance of lipid asym-
metry at the level of the plasmalemma. the relationship between lipid 
number asymmetry and the vesicle radius is given by R = 8kc/h�σ 
or, equivalently, R = 4kc/hK · 1/(δN/N0), where kc, K, h, �σ and 
δN/N0 are the membrane bending modulus, membrane elastic mod-
ulus, membrane thickness, surface tension difference, and the lipid 
number asymmetry between leaflets. Accordingly, lipid number 
asymmetry has been experimentally deduced from studies on cells for 
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impeded
Membrane transverse 






Fig. 2  a relationship between drugs’ MW and their ability to bypass 
the membrane barrier as a function of vesicle radius R (nm) expressed 
in nanometers, scaling as MWc ∼ R3/2 (exactly: MWc ∼= 1.1 R3/2
using constants seen in the text)
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process for creation of adenosine triphosphate (Atp). 
today it is well acknowledged that heterogeneous tumor 
cancer cells organize themselves to use either oxida-
tive or glycolytic metabolism or both, thereby promot-
ing strong survival ability (porporato et al. 2011). A 
direct consequence of cancer cells-specific metabolism 
is a shift in ph, in part associated with the creation of 
lactate (and hydrogen) an end-point of the glycolytic 
metabolism. Further studies have demonstrated that the 
alkalinization of the intracellular ph (phi) of cancer cells 
is accompanied by acidification of the extracellular envi-
ronment (phe) (schornack and Gillies 2003), because 
of the activity of proton pumps including vacuolar-type 
Atpase (v-Atpase), the proton transporters Na+/h+ 
exchanger (NhE), the monocarboxylate transporters 
(Mct), the bicarbonate transporter (Bct), the carbonic 
anhydrases, Atp synthase, and the cl−/hcO3 exchanger 
(Daniel et al. 2013).
the ph gradient phenomenon is now believed to be 
involved in both post-transformation of the neoplastic phe-
notype and activation and etiopathogenesis of the meta-
static process (harguindey et al. 2005, 2009; reshkin et al. 
2000, 2012).
With regard to membrane permeability, ph is an impor-
tant condition because it is related to the concentration of 
free hydrogen ions, which can affect electrostatic interac-
tions between lipids. Because some lipids from the inner 
leaflet (e.g. phosphoinositides, phosphatidylserine, and 
phosphatidic acid) bear a negative charge, they can inter-
act weakly with hydrogen ions, resulting in less repulsion 
between them (Fig. 3) (details are given in Annex 2). As 
a result, ph can cause changes of the surface pressure of 
lipid leaflets and affect the permeability of the resulting 
membrane to drugs, assuming some lipids are negatively 
charged and interact with hydrogen. In this context it has 


























Fig. 3  Effect of ph on the packing of lipids. a Assuming a leaflet 
composed of charged lipids. the optimum area per lipid is deter-
mined by the competition between energy that reflects lipids attrac-
tion linked to their hydrophobic tails and repulsion energy which 
we will assume to be linked to a net charge carried by all lipids. 
the competition between these two terms defines an energy mini-
mum. Note that in the figures r0 corresponds to the optimum dis-
tance between adjacent lipid heads. b thus the minimum energy 
determines the optimum distance between lipids, including their 
optimum area in the monolayer. Note that the packing of lipids is 
not always defined by physical contact and that, accordingly, there 
is room to change this packing. c With regard to negatively charged 
lipids, an increase in the concentration of hydrogen ions enables 
more hydrogen ions to interact with lipids’ heads. thus, by mask-
ing their negative charge, the long-range repulsion between lipids 
is disturbed. the resulting effect will be alteration of the position-
ing of the energy minimum, so the lipids become closer. d top view 
of a portion of the membrane. the lipid’s head is colored in red 
and the optimum area per lipid driven by repulsive and/or attrac-
tive interactions is drawn in blue. changes in ph are expected to 
redefine the optimum area per lipid, and thus their packing. In the 
figure a decrease in the ph is represented, i.e. ph2 < ph1. In con-
clusion, a low cytosolic ph is expected to reduce the surface area 
per lipid. Lipids should have more room, thus reducing their pack-
ing. changing the cytosolic ph is thus expected to affect the pack-
ing of inner leaflet lipids because it is in this leaflet that negatively 
charged lipids are found. to conclude, the packing of lipids can 
vary even though the number of lipids is unchanged. In this case, 
ph-driven alteration of lipid repulsion causes this change. Accord-
ingly, this change is expected to affect the transverse movement of 
drugs across the membrane and thus their efficacy, as demonstrated 
by rauch (2009b)
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driver of drug resistance in cancer (rauch 2009b) and that, 
irrespective of such drug transporters as P-glycoprotein, 
the size of drug is an important physical property in drug 
resistance (rauch 2009a). In this context, the accumula-
tion of anticancer alkaloid drugs inside lysosomes often 
observed in MDr cancer cells results from drugs being 
mechanically trapped at the membrane level and internal-
ized via endocytosis. A change in ph gradient, for exam-
ple via use of proton pump inhibitors, would improve drug 
delivery inside cells.
It follows here that a better understanding of Lipinski’s 
rules enables one to comprehend why ph regulation in can-
cer is so important and why it is a good target for modulat-
ing drug entry into cancer cells. Indeed, ph abnormalities 
in cancer not only modify the charge of weak acids and 
bases (hence their octanol–water partitioning) and their 
ability to interact with the membrane lipid phase, they also 
act on the fluidity of lipid bilayers and therefore on the 
ability of drugs to directly cross membranes.
Lipinski’s rules in cancer cells modulated by proton pump 
inhibitors (ppIs)
Because the ph gradient is important to drug resistance in 
cancer and affects membrane permeability, and because 
tumoral extracellular ph is low, as a result of cancer cell 
metabolism, it may be possible to target ph to control the 
delivery of chemicals into the tumor.
two main strategies have been developed to target the rel-
atively acidic extracellular microenvironment of the tumor. 
First is the development of biologically inert prodrugs of 
the anticancer agents that will release the cytotoxic entities 
under the effect of the low ph. Examples of ph-sensitive 
protecting groups that have been used to mask anticancer 
drug activity include imine, hydrazone, carboxylic hydra-
zone, ketal, acetal, cis-aconityl, and trityl (Binauld and 
stenzel 2013). the second approach is to load the antican-
cer drug into ph-responsive nanocarriers. such nanocar-
riers are designed to be stable under neutral physiological 
ph, and to collapse under slightly acidic ph, releasing the 
entrapped cytotoxic agent within the tumor tissue, followed 
by enhanced drug uptake by cancer cells because of high 
concentration gradients, while maintaining a low rate of 
release during circulation in the blood (shen et al. 2008). 
For example, Lee et al. (2003a) developed ph-destabilizable 
poly(l-histidine)-b-poly(ethylene glycol) (abbreviated as 
phis-pEG)-based micelles. the water-solubility of phis is 
ph-dependent, as a result of protonation of its imidazole sp2 
nitrogen at acidic ph (Fig. 4). the critical micelle concen-
tration (cMc) at ph 8.0 was 2.3 mg/l. the cMc increased 
markedly on reducing the ph. Micelles prepared at ph 8.0 
were gradually destabilized below ph 7.4, and no micelles 
could be detected below ph 5. this increase in cMc at 
lower ph is caused by protonation of the imidazole ring; it 
leads to reduction of its hydrophobicity and increased water 
solubility of the copolymer (Lee et al. 2003b). Loading of 
Fig. 4  Acid-induced drug 
release from ph-responsive 
micelles
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such ph-responsive micelles with doxorubicin (DOX) 
increased its in-vivo plasma half-life (t1/2) and its area under 
the concentration curve (AUc) more than fivefold. simi-
larly, DOX-loaded micelles significantly increased inhibi-
tion of the growth of A2780 xenografts in nude mice after 
i.v. administration compared with free DOX treatment. the 
volume of tumors treated with the ph-sensitive micelles was 
approximately a factor of 4.71 smaller than those treated 
with free DOX after 39 days (Gao et al. 2005). As a result, it 
is possible today to target tissues where the surrounding ph 
is low.
DOX is a weak base; once protonated it cannot traverse 
the membrane. the effect of cancer ph on DOX efficacy 
has already been extensively studied (Altan et al. 1998; 
rauch 2009b). DOX efficacy can be increased by use of 
appropriate ph-sensitive micelles; it can also be improved 
by targeting ph regulation by cancer cells and, in particu-
lar, their ability to release protons. Dual loading of micelles 
with both proton-pump inhibitors (ppIs) and DOX may, in 
fact, increase the efficacy of DOX in the short term. Indeed, 
ppIs would acidify the cytosol, making the membrane more 
fluid with regard to DOX and, at the same time, DOX would 
be released by the micelles to act on its target. Naturally, a 
change in ph (alkalization) of the extracellular environment 
linked to the activity of the ppIs would reform the micelles 
enabling them to keep their unused load for later. Under 
these conditions, loading micelles with DOX and ppIs (or 
other inhibitors of ph regulators, for example NhE, Mct, 
or Bct) can be considered as a new potential strategy 
against cancer.
Conclusion
studies highlighting the membrane as a biomechanical 
object date from the 1970s (sheetz et al. 1976; sheetz and 
singer 1974). since then, much effort has been devoted to 
investigation of the effects of these biomechanical proper-
ties on basic biology. Warburg’s discovery in the 50s dem-
onstrated the importance of ph in cancer; its importance in 
multidrug resistance has been revealed more recently. In 
2001, Lipinski et al. demonstrated the effect of oral drug 
MW on delivery. there are clear overlaps between these 
research fields that require full investigation. Being able 
to harness the delivery of chemicals is still an outstand-
ing challenge for the pharmaceutical industry and cancer 
research and it is hoped that interaction between these 
research fields and biophysics will lead to new ways of 
controlling the delivery of chemicals.
Open Access this article is distributed under the terms of the crea-
tive commons Attribution License which permits any use, distribu-
tion, and reproduction in any medium, provided the original author(s) 
and the source are credited.
Annex 1: effect of membrane physical properties 
on drug permeation
to traverse cellular barriers, drugs must cross lipid mem-
branes. For this, Lipinski’s second rule postulates that drugs 
must have a MW <500. therefore, in the sum of energies 
making up the total activation energy required for a drug to 
cross cellular membranes, there must be an energy term that 
is a specific function of the drug’s dimensions so that the 
drug–membrane interaction yields an energy ≥kBT  (where 
kB is Boltzmann’s constant and T the temperature in Kel-
vin). In this case, i.e. when the plasma membrane is consid-
ered, the physical property that best fits such an interaction 
is the leaflets’ surface pressure, σ. In cells, however, two 
types of membrane tension can be distinguished, the mean 
surface tension denoted σ0, which corresponds to the sum 
of individual leaflet’s surface tension, and the difference 
between surface tensions �σ, which corresponds to the dif-
ference between an individual leaflet’s surface tensions, i.e. 
those of the inner and outer leaflet. however, cells have a 
large membrane reservoir and an average membrane ten-
sion that is remarkably low, |σ0| ∼ 10−2 − 10−3 mN/m 
(hochmuth et al. 1996; raucher and sheetz 1999) com-
pared with the magnitude of the difference in surface ten-
sions between leaflets, |�σ | ∼ 0.9 mN/m (rauch and 
Farge 2000b). Accordingly and given the magnitude of this 
property, �σ is more likely to be involved in impairing the 
transverse movement of chemicals. Dimensionally speak-
ing, it follows that the magnitude of the drug’s critical cross 
section, ac, can be defined by:
In Eq. 2, the minus sign indicates that the membrane 
is compressed when drugs traverse it. the surface ten-
sion difference, �σ, is associated with the effects of lipid 
flippases, which maintain membrane lipid asymmetry 
(seigneuret and Devaux 1984). In particular, it has been 
demonstrated that a particular membrane flippase actively 
relocates phosphatidylserine (ps) and phosphatidyletha-
nolamine (pE) from the outer into the inner leaflet of the 
cell membrane. One consequence of this inward pumping 
is a constantly more highly packed inner leaflet, because it 
contains more phospholipids than the outer leaflet (Fig. 1). 
It has been demonstrated that this lipid packing asymmetry 
between the membrane leaflets leads to fluid phase endocy-
tosis (Devaux 2000; Farge 1995; Farge et al. 1999; rauch 
and Farge 2000b) and that the vesicle radius, R, can be 
expressed as (Fig. 1a) (rauch and Farge 2000b):
where kc and h are, respectively, the membrane bend-
ing modulus and membrane thickness. For small drugs 
their MW is proportional to their van der Walls’ volume 
(2)ac = −kBT/�σ
(3)R = −8kc/h�σ
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(expressed in A˙3), i.e. MW ∼ V ∼ a3/2, by using Eqs. 1 
and 2, a critical MW (MWc) can be determined (rauch and 
pluen 2007):
Eq. 4 is Eq. 1 in the text.
Annex 2: effect of pH on lipid–lipid interaction
to determine and model how ph alters the mechanical 
properties of the cell membrane we consider the thermo-
dynamic equilibrium of an ideal leaflet, namely a surface 
S, composed of N identical lipids. the optimum area per 
lipid in the monolayer, a0, can be determined by optimiz-
ing the contribution of different energies arising from the 
structural properties of lipids, of which the main interac-
tions are hydrophobic, steric, and electrostatic. the elec-
trostatic interactions between lipids can be subdivided into 
charge–charge, charge–dipole and dipole–dipole inter-
actions. however, the magnitudes of charge–dipole and 
dipole–dipole interactions are much weaker and relatively 
short-range compared with strong and long-range charge–
charge interactions (≫ kBT , where kB and T  are, respec-
tively, Boltzmann’s constant and the temperature in Kelvin) 
(Gershel 1995). therefore, the hydrophobic interaction will 
be represented by a single energy term (E1). the membrane 
energy resulting from steric, charge–dipole, and dipole–
dipole interactions (both short-range, relatively weak 
interactions ∼ kBT) will be represented by a single energy 
term (E2). Finally, E3 will characterize the charge–charge 
interactions (≫ kBT). the first energy (E1) is linked to the 
non-polar (hydrophobic) part of the lipids, and increases as 
the surface area per lipid increases (because of contact with 
water). As a result, this term is positive and proportional to 
the non optimized area per lipid, a, written in the form:
where K has the dimensions of tension (i.e. a 2D elastic 
modulus).
the second energy (E2) describes short-range and weak 
interactions between lipids. this energy is proportional to 
the lipid density (N/S) and to the number of close neigh-
borhoods, z, located in the vicinity of each lipid. consider a 
2D lattice in which each site is occupied by a lipid. In this 
lattice, the probability of the presence of a given lipid is 
∼ (N/S)θ2 where the characteristic length that defines the 
lattice mesh is θ, and is expected to be numerically close to 
the lipid head radius, assuming a rod-like shape for lipids. 
As one considers weak interactions only, the interaction 
energy per lipid is ∼ zε˜(N/S)θ2, where the number of close 
neighborhoods is z and ε˜ is the typical energy involved in 





each lipid of the monolayer it follows that the total inter-
action energy is ∼ zε˜(N/S)θ2N/2, where the factor 1/2 is 
present to avoid counting the same pair-interaction twice. 
Finally, noting zε˜θ2 = ν · kBT , where ν is similar to the 
second viral coefficient of a 2D polar head gas, it follows 
that this energy can be written as E2 = NkBTν/2 · (N/S). 
Given that N/S = 1/a it follows:
the third energy of interest (E3) is the energy between 
charged lipids. One will assume homogenous distribution 
of charged lipids in the membrane and that, because of the 
presence of free cytosolic electrolytes, the net charge of the 
lipid is screened over a critical lateral length lc, which is 
Debye’s length (Nguyen et al. 2005). Note that lc is classi-
cally defined as the square root of the sum of squared ionic 
concentrations and any changes in the membrane potential, 
reflected by a change in ionic concentrations, would affect 
lc. One will note p0 the probability that a given lipid in the 
monolayer is charged, i.e. p0 is the ratio between the num-
ber of charged lipids and the total number of lipids. Under 
such conditions, a given charged lipid can affect another 
charged lipid only if the latter is within the surface area 
defined by the critical length lc and expressed as π l2c and 
the probability that a given charged lipid interacts with 
another is p0π l2c/a, where π l2c/a is the number of lipids 
in the surface area. It follows that the interaction energy 
between a given charged lipid and another in the monolayer 
can be written as ε¯(lc)p0π l2c/a, where ε¯(lc) is the interac-
tion energy that is also a function of the critical length lc. 
repeating the same operation over each charged lipid com-
posing the monolayer, without counting the same pair-
interaction twice, it follows that:
In Eq. 7, a literal expression of ε¯(lc) must be given. As a 
mean field approach has been considered so far, ε¯(lc) repre-
sents the characteristic energy linked to electrostatic inter-
actions between two charges, i.e. ε¯(lc) ∼ q2/Dlc, where 
q and D are the monovalent lipid charge and the dielec-
tric constant of water respectively (Nguyen et al. 2005). 
Assuming ε¯(lc) = ε¯0/lc where ε¯0 is a function of the charge 
and the dielectric constant it follows that:
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Assuming that a hydrogen ion and a negatively charged 
lipid interact with energy −e0 (e0 > 0 is the magnitude of 
the interaction). In this case, each negatively charged lipid 
can be in two states, occupied (i.e. interacting with hydro-
gen ion) or non-occupied (i.e. free of hydrogen ion). It fol-
lows that the partition function of a negatively charged lipid 
is ζ = 1 + e(e0+µ)/kBT (µ ∼ kBT ln (CH+ × V0/VH+) is the 
chemical potential of hydrogen ion in solution and CH+, 
VH+ and V0 are, respectively, the volume concentration of 
hydrogen, the volume of an hydrogen ion, and the typical 
volume of ions in the cytosol). Using statistical physics, the 
probability that a lipid is free from hydrogen is p0 = 1/ζ. 
this last relationship in conjunction with Eq. 9 provides 
the relationship between the free surface area per lipid and 
the volume concentration of ions in solution.
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